Hotgen Biotech is a biotechnology company focusing on in-vitro diagnostics (IVD) and antibody medicines. self-described as an innovator in the field, developing various IVD technology platforms.

Beijing Hotgen Biotech Co., Ltd

Hotgen Biotech

Beijing Hotgen Biotech Co., Ltd | 2,375 followers on LinkedIn. Advanced manufacturer in the field of medicine and public safety | Hotgen Biotech Co., Ltd was founded in 2005 and is located in the Biomedical Base of Zhongguancun High-Tech Park in Beijing. It is a national-level high-tech company dedicated to developing and manufacturing innovative in-vitro diagnostic (IVD), point-of-care testing (POCT), and biodefense products.

Now, Hotgen has four technology platforms:

1.

Medical laboratories (IVD) , international Sales Consultant, Country Manager (Egypt), CLIA, Automated Clinical chemistry. Quality controls…

kareem Ahmed khalifa

北京热景生物技术有限公司 - 客服主管

韩丽丽

北京热景生物技术有限公司 - 行政专员

张雪莲

职工 - 热景

赵直

November is International Lung Cancer Awareness Month, which aims to raise awareness of lung cancer, one of the most common and deadly cancers in the world. As an important tool for early diagnosis and monitoring, Hotgen's five-item lung cancer test can help medical experts comprehensively and quickly obtain multiple biomarker information on patients and improve the accuracy of early screening. This not only helps early detection and personalized treatment plans, but also improves patient survival rates. Let us pay attention to early screening for lung cancer and protect life and health with science.

Each year on November 14th, the World Health Organization (WHO) and the International Diabetes Federation (IDF) jointly observe World Diabetes Day to raise public awareness of the health risks associated with diabetes. Diabetes not only affects patients' physical health but also imposes a significant social burden. According to the International Diabetes Federation, more than 460 million people worldwide are currently living with diabetes, and this number is expected to continue rising in the coming decades. Therefore, increasing awareness of diabetes prevention and treatment, as well as ensuring equitable access to diabetes care resources, is a pressing challenge for global healthcare. As a leading biotechnology company in China, Hotgen remains committed to providing high-quality, reliable diabetes testing products to support global efforts in diabetes prevention and control. We call on society to join forces in addressing the diabetes crisis, promoting the widespread adoption of health management strategies, and ensuring that diabetes patients receive timely medical care, thus improving their quality of life. Hotgen is dedicated to working alongside you towards a healthier future！

Innovative Diagnostics, Empowered by Intelligence | Hotgen's Successful Debut at MEDICA 2024 From November 11 to 14, 2024, the international medical device exhibition MEDICA 2024 was successfully held in Düsseldorf, Germany. Beijing Hotgen Biotechnology Co., Ltd. set up two booths at the event, located at Hall 3 (3 96-4) and Hall 1 (1 A 07), attracting visitors and industry experts from around the world. During the exhibition, Hotgen showcased a range of highly recognized innovative products, including the compact and intelligent MQ60 series single-use chemiluminescence system, the UPT ultra-sensitive luminescent immunoassay solution, as well as highly accurate small molecule sandwich diagnostic reagents and IVD reagent raw materials. These products demonstrated the company's leading technologies and R&D capabilities in the field of in vitro diagnostics, earning high praise and attention from visitors. Adhering to its mission of "Advancing Biotechnology for the Benefit of Human Health," Hotgen continues to drive innovation and development in in vitro diagnostic technology. This exhibition further deepened global partners' understanding of the company's products and technologies, laying a solid foundation for future collaboration. Hotgen sincerely thanks every visitor for their attention and support and looks forward to more international opportunities in the future, working together with global partners to continuously advance medical diagnostic technologies.

Innovative diagnosis and intelligent empowerment | Hotgen sincerely invites you to attend the 2024 Medica exhibition in Germany The 2024 German International Medical Equipment Exhibition (Medica) will be held in Dusseldorf, Germany from November 11th to 14th. Beijing Hotgen Biotech Co., Ltd. has set up two booths in this exhibition, located at 3F 96-4 in Hall 3 and 1A 07 in Hall 1. During the period, we will showcase the market-recognized compact and smart MQ60 series of mono-test chemiluminescence and up-converting phosphor(UPT) luminescence immunoassay solutions as well as highly accurate small molecule sandwich method diagnostic reagents and IVD reagent raw materials. In addition, we will hold a shocking new product release session during the exhibition, and an innovative technology will be unveiled for the first time, bringing unprecedented new testing capabilities to medical laboratories around the world. Holding the mission of "developing biotechnology, benefiting human health", Hotgen sincerely welcome all global partners to visit our booths to explore our innovative IVD products and technologies, and to jointly promote the improvement of global medical testing capabilities. Thank you for your attention and support, and we look forward to having in-depth exchanges with you at the exhibition!

Innovate Diagnostics for Value Creation | Hotgen successfully debuted at KONKER XI & PIT XXIII 2024 with its new in vitro diagnostic solution From October 23 to 25, 2024, Beijing Hotgen Biotech Co., Ltd. successfully participated in the PANITIA KONFERENSI KERJA (KONKER) XI & PERTEMUAN ILMIAH TAHUNAN (PIT) XXIII 2024, held at the PADMA HOTEL in Semarang, Indonesia. At this exhibition, Hotgen exhibited its market-recognized mono-test chemiluminescence and up-converting phosphor immunoassay solutions, breakthrough technologies for small molecule immunoassays, and a variety of colloidal gold rapid test products, attracting the attention and consultation of many participants. As a high-tech enterprise committed to "developing biotechnology and benefiting human health", Hotgen actively promotes advanced IVD (in vitro diagnostic) technology to help improve the capabilities of Indonesian testing laboratories. During the exhibition, many industry experts and partners came to Hotgen's booth to discuss the development prospects of accurate and convenient diagnostic and physical examination solutions in Indonesia. Through this exhibition, Hotgen has further deepened its ties with the Indonesia market and demonstrated its cutting-edge technology and strength in the field of in vitro diagnostics. Thank you for your attention and support, and we are looking forward to cooperating with you in the future to jointly promote the development of regional health career.

The theme of World Stroke Day 2024 emphasizes leveraging the emotional power of sports to raise stroke awareness and encourage global action to reduce stroke risk. In the diagnosis of acute ischemic stroke, the combined testing of NSE, S100, and D-dimer (D-D) has shown higher sensitivity and accuracy. NSE is a specific marker for neuronal damage, S100 reflects the extent of brain injury, and D-dimer testing can indicate the potential risk of thrombosis in the body. This combined testing allows for a comprehensive assessment of stroke patients' conditions from different perspectives, effectively reducing the rate of missed diagnoses. Compared to testing a single biomarker, this combination not only improves the accuracy of early diagnosis but also provides doctors with a more complete clinical reference, aiding in the development of more precise treatment plans. On World Stroke Day, we call on everyone to recognize the importance of combined testing of NSE, S100, and D-dimer, contributing to better stroke diagnosis and treatment, and supporting global stroke prevention efforts. Hotgen mono-test chemiluminescent immunoassay analyzer and reagents NSE, S100 and D-dimer joint detection help early and accurate diagnosis of stroke. #World Stroke Day #Hotgen https://lnkd.in/gfuzh4fx

HOTG

COM:HOTGENBIOTECH

Hotgen Biotech

name

homepage url

country

linkedin url

crunchbase url

sector

industry

Description

competitor of

Metrics